Clazakizumab (Anti-Interleukin 6 (IL-6) Monoclonal) Compared to Placebo for Coronavirus Disease 2019 (COVID-19)
Clinical trial NCT04348500 · COMPLETED
Trial details
- NCT number
- NCT04348500
- Sponsor
- Cedars-Sinai Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-28
- Primary completion
- 2020-09-30
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.